Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)

CUSIP: 471871202

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Voting Common Stock
Total 13F shares
12,514,434
Total 13F value
$69,456,410
Holder snapshot 6 visible 7 signals
Share change
-520,044
Put/Call ratio
189%
SEC-reported price per share
$5.55
Number of holders
63
Value change
-$2,535,024
Number of buys
32
Open additional details 1 more signal available
Number of sells
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,779,583

Security key

471871202

Report period

Q2 2025

Institutions

63

Top holders

10

JSPR full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Jasper Therapeutics, Inc. SEC filings Jasper Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
Velan Capital Investment ...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F 13D/G 3/4/5 Lead comparable stake: 1.5% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 1.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 1.5%
Soleus Capital Management, L.P. 5.4%
Velan Capital Investment Manageme... 5.2%
Carlyle Group Inc. 3.8%
Qiming U.S. Ventures Management, LLC 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
1.5%
from 13D/G
$3,386,702
787,605 shares
 — 31 Mar 2025
Soleus Capital Management, L.P.
13F
Company
13F
5.4%
$6,426,006
1,494,420 shares
 — 31 Mar 2025
Velan Capital Investment Management LP
3/4/5 13F
10%+ Owner · Company
3/4/5 13F
5.2%
from 13F
$18,568,073
1,433,828 shares
 — 08 Feb 2024
Carlyle Group Inc.
3/4/5 13F
Former 10% Owner · Company
3/4/5 13F
3.8%
from 13F
$13,807,148
1,066,189 shares
 — 08 Feb 2024
Qiming U.S. Ventures Management, LLC
13F
Company
13F
3.3%
$3,994,545
928,964 shares
 — 31 Mar 2025
T. Rowe Price Investment Management, Inc.
13F
Company
13F
2.5%
$3,022,000
702,757 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
63
Shares
12,514,434
Rows available
63
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
66
Q2 2025 holders
63
Holder diff
-3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .